Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 284


Cancer Proteomics and the Elusive Diagnostic Biomarkers.

Bradshaw RA, Hondermarck H, Rodriguez H.

Proteomics. 2019 Jun 7:e1800445. doi: 10.1002/pmic.201800445. [Epub ahead of print]


An Engineered Human Fibroblast Growth Factor-1 Derivative, TTHX1114, Ameliorates Short-term Corneal Nitrogen Mustard Injury in Rabbit Organ Cultures.

Eveleth DD, Eveleth JJ, Subramaniam A, Hahn R, Zhou P, Gordon MK, Bradshaw RA.

Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4720-4730. doi: 10.1167/iovs.18-24568.


Nerve Growth Factor and Related Substances: A Brief History and an Introduction to the International NGF Meeting Series.

Bradshaw RA, Mobley W, Rush RA.

Int J Mol Sci. 2017 May 26;18(6). pii: E1143. doi: 10.3390/ijms18061143. Review.


Unambiguous high resolution genotyping of human leukocyte antigens.

Bradshaw RA, Dunn PPJ.

J Immunol Methods. 2017 Jun;445:10-14. doi: 10.1016/j.jim.2017.02.011. Epub 2017 Feb 24.


New Guidelines for Publication of Manuscripts Describing Development and Application of Targeted Mass Spectrometry Measurements of Peptides and Proteins.

Abbatiello S, Ackermann BL, Borchers C, Bradshaw RA, Carr SA, Chalkley R, Choi M, Deutsch E, Domon B, Hoofnagle AN, Keshishian H, Kuhn E, Liebler DC, MacCoss M, MacLean B, Mani DR, Neubert H, Smith D, Vitek O, Zimmerman L.

Mol Cell Proteomics. 2017 Mar;16(3):327-328. doi: 10.1074/mcp.E117.067801. Epub 2017 Feb 9. No abstract available.


Proteomics in India: A Report on a Brainstorming Meeting at Hyderabad, India.

Chatterjee B, Makarov A, Clemmer DE, Steen H, Steen J, Saffell-Clemmer W, Moghekar AR, Mohan Rao C, Bradshaw RA, Thakur SS.

Mol Cell Proteomics. 2016 Jul;15(7):2229-35. doi: 10.1074/mcp.O115.055020. Epub 2016 Apr 25.


Prevalence of obesity in panama: some risk factors and associated diseases.

Mc Donald A, Bradshaw RA, Fontes F, Mendoza EA, Motta JA, Cumbrera A, Cruz C.

BMC Public Health. 2015 Oct 21;15:1075. doi: 10.1186/s12889-015-2397-7.


Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.

Dun MD, Chalkley RJ, Faulkner S, Keene S, Avery-Kiejda KA, Scott RJ, Falkenby LG, Cairns MJ, Larsen MR, Bradshaw RA, Hondermarck H.

Mol Cell Proteomics. 2015 Sep;14(9):2316-30. doi: 10.1074/mcp.M114.046110. Epub 2015 Jun 3.


On Credibility, Clarity, and Compliance.

Burlingame A, Carr SA, Bradshaw RA, Chalkley RJ.

Mol Cell Proteomics. 2015 Jul;14(7):1731-3. doi: 10.1074/mcp.E115.052506. Epub 2015 Jun 3. No abstract available.


Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancer.

Pundavela J, Roselli S, Faulkner S, Attia J, Scott RJ, Thorne RF, Forbes JF, Bradshaw RA, Walker MM, Jobling P, Hondermarck H.

Mol Oncol. 2015 Oct;9(8):1626-35. doi: 10.1016/j.molonc.2015.05.001. Epub 2015 May 14.


Minireviews revisited.

Bradshaw RA, Burlingame AL.

Mol Cell Proteomics. 2015 Mar;14(3):455. doi: 10.1074/mcp.E115.048868. Epub 2015 Feb 5. No abstract available.


NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.

Bradshaw RA, Pundavela J, Biarc J, Chalkley RJ, Burlingame AL, Hondermarck H.

Adv Biol Regul. 2015 May;58:16-27. doi: 10.1016/j.jbior.2014.11.003. Epub 2014 Nov 20. Review.


ProNGF correlates with Gleason score and is a potential driver of nerve infiltration in prostate cancer.

Pundavela J, Demont Y, Jobling P, Lincz LF, Roselli S, Thorne RF, Bond D, Bradshaw RA, Walker MM, Hondermarck H.

Am J Pathol. 2014 Dec;184(12):3156-62. doi: 10.1016/j.ajpath.2014.08.009. Epub 2014 Oct 5.


Dick Hanson and the launch of MCP: a personal reflection.

Bradshaw RA.

Mol Cell Proteomics. 2014 May;13(5):1150-2. doi: 10.1074/mcp.O114.040170. Epub 2014 Apr 7. No abstract available.


Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.

Carr SA, Abbatiello SE, Ackermann BL, Borchers C, Domon B, Deutsch EW, Grant RP, Hoofnagle AN, Hüttenhain R, Koomen JM, Liebler DC, Liu T, MacLean B, Mani DR, Mansfield E, Neubert H, Paulovich AG, Reiter L, Vitek O, Aebersold R, Anderson L, Bethem R, Blonder J, Boja E, Botelho J, Boyne M, Bradshaw RA, Burlingame AL, Chan D, Keshishian H, Kuhn E, Kinsinger C, Lee JS, Lee SW, Moritz R, Oses-Prieto J, Rifai N, Ritchie J, Rodriguez H, Srinivas PR, Townsend RR, Van Eyk J, Whiteley G, Wiita A, Weintraub S.

Mol Cell Proteomics. 2014 Mar;13(3):907-17. doi: 10.1074/mcp.M113.036095. Epub 2014 Jan 17.


Western blots versus selected reaction monitoring assays: time to turn the tables?

Aebersold R, Burlingame AL, Bradshaw RA.

Mol Cell Proteomics. 2013 Sep;12(9):2381-2. doi: 10.1074/mcp.E113.031658. Epub 2013 Jun 10. No abstract available.


Dissecting the roles of tyrosines 490 and 785 of TrkA protein in the induction of downstream protein phosphorylation using chimeric receptors.

Biarc J, Chalkley RJ, Burlingame AL, Bradshaw RA.

J Biol Chem. 2013 Jun 7;288(23):16606-18. doi: 10.1074/jbc.M113.475285. Epub 2013 Apr 15.


Rita Levi-Montalcini (1909-2012).

Bradshaw RA.

Nature. 2013 Jan 17;493(7432):306. doi: 10.1038/493306a. Epub 2013 Jan 9. No abstract available.


Receptor tyrosine kinase signaling mechanisms: Devolving TrkA responses with phosphoproteomics.

Bradshaw RA, Chalkley RJ, Biarc J, Burlingame AL.

Adv Biol Regul. 2013 Jan;53(1):87-96. doi: 10.1016/j.jbior.2012.10.006. Epub 2012 Nov 3. Review.


N-terminal protein processing: a comparative proteogenomic analysis.

Bonissone S, Gupta N, Romine M, Bradshaw RA, Pevzner PA.

Mol Cell Proteomics. 2013 Jan;12(1):14-28. doi: 10.1074/mcp.M112.019075. Epub 2012 Sep 23.


Pro-nerve growth factor induces autocrine stimulation of breast cancer cell invasion through tropomyosin-related kinase A (TrkA) and sortilin protein.

Demont Y, Corbet C, Page A, Ataman-Önal Y, Choquet-Kastylevsky G, Fliniaux I, Le Bourhis X, Toillon RA, Bradshaw RA, Hondermarck H.

J Biol Chem. 2012 Jan 13;287(3):1923-31. doi: 10.1074/jbc.M110.211714. Epub 2011 Nov 29.


The induction of serine/threonine protein phosphorylations by a PDGFR/TrkA chimera in stably transfected PC12 cells.

Biarc J, Chalkley RJ, Burlingame AL, Bradshaw RA.

Mol Cell Proteomics. 2012 May;11(5):15-30. doi: 10.1074/mcp.M111.013375. Epub 2011 Oct 25.


Time to articulate a vision for the future of plant proteomics - A global perspective: An initiative for establishing the International Plant Proteomics Organization (INPPO).

Agrawal GK, Job D, Zivy M, Agrawal VP, Bradshaw RA, Dunn MJ, Haynes PA, van Wijk KJ, Kikuchi S, Renaut J, Weckwerth W, Rakwal R.

Proteomics. 2011 May;11(9):1559-68. doi: 10.1002/pmic.201000608. Epub 2011 Mar 23.


Receptor tyrosine kinase signaling--a proteomic perspective.

Biarc J, Chalkley RJ, Burlingame AL, Bradshaw RA.

Adv Enzyme Regul. 2011;51(1):293-305. doi: 10.1016/j.advenzreg.2010.10.005. Epub 2010 Nov 5. Review.


Technological innovation revisited.

Bradshaw RA, Burlingame AL.

Mol Cell Proteomics. 2010 Nov;9(11):2335-6. doi: 10.1074/mcp.E110.005447. Epub 2010 Oct 13. No abstract available.


Protein PTMs: post-translational modifications or pesky trouble makers?

Bradshaw RA, Medzihradszky KF, Chalkley RJ.

J Mass Spectrom. 2010 Oct;45(10):1095-7. doi: 10.1002/jms.1786.


What has proteomics accomplished?

Bergeron JJ, Bradshaw RA.

Mol Cell Proteomics. 2007 Oct;6(10):1824-6. No abstract available.


How I became a biochemist.

Bradshaw RA.

IUBMB Life. 2006 Aug;58(8):495-8. No abstract available.


Reporting protein identification data: the next generation of guidelines.

Bradshaw RA, Burlingame AL, Carr S, Aebersold R.

Mol Cell Proteomics. 2006 May;5(5):787-8. No abstract available.


Revised draft guidelines for proteomic data publication.

Bradshaw RA.

Mol Cell Proteomics. 2005 Sep;4(9):1223-5. No abstract available.


Protein identification: the good, the bad, and the ugly.

Bradshaw RA, Burlingame AL, Carr S, Aebersold R.

Mol Cell Proteomics. 2005 Sep;4(9):1221-2. No abstract available.


From proteins to proteomics.

Bradshaw RA, Burlingame AL.

IUBMB Life. 2005 Apr-May;57(4-5):267-72. Review.


Characterization of symmetric complexes of nerve growth factor and the ectodomain of the pan-neurotrophin receptor, p75NTR.

Aurikko JP, Ruotolo BT, Grossmann JG, Moncrieffe MC, Stephens E, Leppänen VM, Robinson CV, Saarma M, Bradshaw RA, Blundell TL.

J Biol Chem. 2005 Sep 30;280(39):33453-60. Epub 2005 Jul 11.


Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells.

Nowroozi N, Raffioni S, Wang T, Apostol BL, Bradshaw RA, Thompson LM.

Hum Mol Genet. 2005 Jun 1;14(11):1529-38. Epub 2005 Apr 20.


Nerve growth factor expression response to induction agent booster dosing in transfected human embryonic kidney cells.

McConnell MP, Dhar S, Nguyen T, Naran S, Calvert JW, Sundine MJ, Bradshaw RA, Evans GR.

Plast Reconstr Surg. 2005 Feb;115(2):506-14.


In vivo induction and delivery of nerve growth factor, using HEK-293 cells.

McConnell MP, Dhar S, Naran S, Nguyen T, Bradshaw RA, Evans GR.

Tissue Eng. 2004 Sep-Oct;10(9-10):1492-501.


A review of the therapeutic uses of thrombin.

Lundblad RL, Bradshaw RA, Gabriel D, Ortel TL, Lawson J, Mann KG.

Thromb Haemost. 2004 May;91(5):851-60. Review.


Human embryonic kidney cells (HEK-293 cells): characterization and dose-response relationship for modulated release of nerve growth factor for nerve regeneration.

Jimenez JC, Tyson DR, Dhar S, Nguyen T, Hamai Y, Bradshaw RA, Evans GR.

Plast Reconstr Surg. 2004 Feb;113(2):605-10.


O-sulfonation of serine and threonine: mass spectrometric detection and characterization of a new posttranslational modification in diverse proteins throughout the eukaryotes.

Medzihradszky KF, Darula Z, Perlson E, Fainzilber M, Chalkley RJ, Ball H, Greenbaum D, Bogyo M, Tyson DR, Bradshaw RA, Burlingame AL.

Mol Cell Proteomics. 2004 May;3(5):429-40. Epub 2004 Jan 29.


Individual and combined effects of TrkA and p75NTR nerve growth factor receptors. A role for the high affinity receptor site.

Lad SP, Peterson DA, Bradshaw RA, Neet KE.

J Biol Chem. 2003 Jul 4;278(27):24808-17. Epub 2003 Apr 17.


PC12 cell activation by epidermal growth factor receptor: role of autophosphorylation sites.

Tyson DR, Larkin S, Hamai Y, Bradshaw RA.

Int J Dev Neurosci. 2003 Apr;21(2):63-74.


Methionine aminopeptidases and angiogenesis.

Bradshaw RA, Yi E.

Essays Biochem. 2002;38:65-78. Review.


Proteomics - boom or bust?

Bradshaw RA.

Mol Cell Proteomics. 2002 Mar;1(3):177-8. No abstract available.


The role of tyrosine residues in fibroblast growth factor receptor 1 signaling in PC12 cells. Systematic site-directed mutagenesis in the endodomain.

Foehr ED, Raffioni S, Murray-Rust J, Bradshaw RA.

J Biol Chem. 2001 Oct 5;276(40):37529-36. Epub 2001 Jul 17.


Expression of the urokinase plasminogen activator receptor is transiently required during "priming" of PC12 cells in nerve growth factor-directed cellular differentiation.

Farias-Eisner R, Vician L, Reddy S, Basconcillo R, Rabbani SA, Wu YY, Bradshaw RA, Herschman HR.

J Neurosci Res. 2001 Feb 15;63(4):341-6.


NF-kappa B signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells.

Foehr ED, Lin X, O'Mahony A, Geleziunas R, Bradshaw RA, Greene WC.

J Neurosci. 2000 Oct 15;20(20):7556-63.


Discoidin domain receptor 1 (DDR1) signaling in PC12 cells: activation of juxtamembrane domains in PDGFR/DDR/TrkA chimeric receptors.

Foehr ED, Tatavos A, Tanabe E, Raffioni S, Goetz S, Dimarco E, De Luca M, Bradshaw RA.

FASEB J. 2000 May;14(7):973-81.


Nerve growth factor alpha subunit: effect of site-directed mutations on catalytic activity and 7S NGF complex formation.

Yarski MA, Bax BD, Hogue-Angeletti RA, Bradshaw RA.

Biochim Biophys Acta. 2000 Mar 7;1477(1-2):253-66.


Special issue in honor of hans Neurath's 90th birthday

Bradshaw RA, Travis J.

Biochim Biophys Acta. 2000 Mar 7;1477(1-2):1. No abstract available.


Supplemental Content

Loading ...
Support Center